baicalin has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, SC; Dong, X; Li, N; Mai, YX; Pang, FX; Wang, JY; Wen, RJ; Zhang, JF; Zhou, ST; Zhuang, HW | 1 |
| Fang, Q; Ge, H; Huang, T; Li, M; Wang, B; Yuan, J; Zhang, X | 1 |
| Chai, Y; Lu, S; Ma, Z; Wang, H; Wang, Y; Zhong, W; Zhou, R | 1 |
3 other study(ies) available for baicalin and Bone Cancer
| Article | Year |
|---|---|
Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
Topics: Animals; Bone Neoplasms; Disease Models, Animal; Ferroptosis; Glutathione Disulfide; Humans; Mice; NF-E2-Related Factor 2; Osteosarcoma | 2023 |
Bone-protective and anti-tumor effect of baicalin in osteotropic breast cancer via induction of apoptosis.
Topics: Animals; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Flavonoids; Humans; Mice; Osteoclasts; Quality of Life; Tumor Microenvironment | 2020 |
Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
Topics: Anoikis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavonoids; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2017 |